RU94031127A - ACTIVITY INHIBITORS OF GENDER STEROIDS - Google Patents

ACTIVITY INHIBITORS OF GENDER STEROIDS

Info

Publication number
RU94031127A
RU94031127A RU94031127/04A RU94031127A RU94031127A RU 94031127 A RU94031127 A RU 94031127A RU 94031127/04 A RU94031127/04 A RU 94031127/04A RU 94031127 A RU94031127 A RU 94031127A RU 94031127 A RU94031127 A RU 94031127A
Authority
RU
Russia
Prior art keywords
steroids
gender
activity inhibitors
pharmaceutical preparations
inhibitors
Prior art date
Application number
RU94031127/04A
Other languages
Russian (ru)
Other versions
RU2142945C1 (en
Inventor
Лабри Фернанд
Меранд Ив
Original Assignee
Андорешерш Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/801,704 external-priority patent/US5395842A/en
Application filed by Андорешерш Инк. filed Critical Андорешерш Инк.
Publication of RU94031127A publication Critical patent/RU94031127A/en
Application granted granted Critical
Publication of RU2142945C1 publication Critical patent/RU2142945C1/en

Links

Claims (1)

Ингибиторы активности половых стероидов, например соответствующих общей формуле А
Figure 00000001

могут быть использованы в качестве компонентов фармацевтических препаратов для создания антиэстрогенного действия и/или подавления синтеза эстрогена. Подобные фармацевтические препараты применимы для лечения рака молочной железы или других заболеваний, развитию которых способствует активация рецепторов половых стероидов.Inhibitors of the activity of sex steroids, for example, corresponding to the general formula A
Figure 00000001

can be used as components of pharmaceutical preparations to create an anti-estrogenic effect and / or suppress estrogen synthesis. Such pharmaceutical preparations are applicable for the treatment of breast cancer or other diseases, the development of which contributes to the activation of sex steroid receptors.
RU94031127A 1991-12-02 1992-12-01 Benzopiperidine derivatives, bicyclic compounds and pharmaceutical composition based on said RU2142945C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/801,704 US5395842A (en) 1988-10-31 1991-12-02 Anti-estrogenic compounds and compositions
US07/801,704 1991-12-02
PCT/CA1992/000518 WO1993010741A2 (en) 1991-12-02 1992-12-01 Sex steroid activity inhibitors

Publications (2)

Publication Number Publication Date
RU94031127A true RU94031127A (en) 1996-03-20
RU2142945C1 RU2142945C1 (en) 1999-12-20

Family

ID=25181845

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94031127A RU2142945C1 (en) 1991-12-02 1992-12-01 Benzopiperidine derivatives, bicyclic compounds and pharmaceutical composition based on said

Country Status (19)

Country Link
US (2) US5395842A (en)
EP (1) EP0615448B1 (en)
JP (3) JP2784846B2 (en)
KR (1) KR100383555B1 (en)
AT (1) ATE216880T1 (en)
AU (1) AU4677297A (en)
CA (1) CA2124932C (en)
DE (1) DE69232590T2 (en)
DK (1) DK0615448T3 (en)
ES (1) ES2176190T3 (en)
FI (1) FI121376B (en)
IL (1) IL103941A (en)
MY (1) MY117275A (en)
NO (1) NO315234B1 (en)
NZ (3) NZ245339A (en)
RU (1) RU2142945C1 (en)
TW (1) TW240215B (en)
WO (1) WO1993010741A2 (en)
ZA (1) ZA929309B (en)

Families Citing this family (173)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686465A (en) * 1988-10-31 1997-11-11 Endorecherche Inc. Sex steroid activity inhibitors
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
USRE38968E1 (en) 1992-07-28 2006-02-07 Eli Lilly And Company Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
USRE39049E1 (en) 1992-07-28 2006-03-28 Eli Lilly And Company Methods for inhibiting bone loss
TW366342B (en) 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5770609A (en) 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
BR9307277A (en) * 1992-10-21 1999-05-11 Pfizer Sulphonamide derivatives of cycloalkyl and heterocyclic ring compounds substituted with hydroxy condensed with benzene
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
ATE406909T1 (en) * 1993-05-13 2008-09-15 Poniard Pharmaceuticals Inc PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMAL PROLIFERATION OF SMOOTH MUSCLE CELLS
US6197789B1 (en) 1995-06-07 2001-03-06 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US5461065A (en) * 1993-10-15 1995-10-24 Eli Lilly And Company Methods for inhibiting endometriosis
US5457113A (en) * 1993-10-15 1995-10-10 Eli Lilly And Company Methods for inhibiting vascular smooth muscle cell proliferation and restinosis
CN1058390C (en) * 1993-10-15 2000-11-15 伊莱利利公司 Methods for exhibiting angiogenisis and angiogenic diseases
US5418252A (en) * 1993-10-15 1995-05-23 Eli Lilly And Company Method for inhibiting cartilage degradation
US5480904A (en) * 1993-10-28 1996-01-02 Eli Lilly And Company Methods for inhibiting uterine fibrosis
US5446061A (en) * 1993-11-05 1995-08-29 Eli Lilly And Company Methods for lowering serum cholesterol
US5407947A (en) * 1993-11-05 1995-04-18 Eli Lilly And Company Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans
US6489355B2 (en) * 1993-12-01 2002-12-03 Eli Lilly And Company Methods of inhibiting the effects of amyloidogenic proteins
US6417198B1 (en) 1993-12-21 2002-07-09 Eli Lilly And Company Methods of inhibiting CNS problems in post-menopausal women
US5439931A (en) * 1993-12-21 1995-08-08 Eli Lilly And Company Method for increasing libido in post-menopausal women
US5521198A (en) * 1993-12-21 1996-05-28 Eli Lilly And Company Methods of inhibiting autoimmune diseases
US5439923A (en) * 1993-12-21 1995-08-08 Eli Lilly And Company Method of inhibiting seborrhea and acne
US5596004A (en) * 1993-12-21 1997-01-21 Eli Lilly And Company Methods of inhibiting male infertility
US5462949A (en) * 1993-12-21 1995-10-31 Eli Lilly And Company Methods of inhibiting fertility in women
US5534526A (en) * 1993-12-21 1996-07-09 Eli Lilly And Company Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome
US5451590A (en) * 1993-12-21 1995-09-19 Eli Lilly & Co. Methods of inhibiting sexual precocity
US5441965A (en) * 1993-12-21 1995-08-15 Eli Lilly And Company Methods of inhibiting thrombin
US5462950A (en) * 1993-12-21 1995-10-31 Eli Lilly And Company Methods of treating menstrual symptoms and compositions therefore
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair
US5578613A (en) * 1993-12-21 1996-11-26 Eli Lilly And Company Methods for inhibiting weight gain or inducing weight loss
US5451589A (en) * 1993-12-21 1995-09-19 Eli Lilly And Company Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism
CZ321394A3 (en) * 1993-12-21 1995-08-16 Lilly Co Eli Pharmaceutical preparation for inhibiting woman hirsutism and alopecia
US5492927A (en) * 1993-12-21 1996-02-20 Eli Lilly And Company Non-peptide tachykinin receptor antagonists to treat allergy
US5672610A (en) * 1993-12-21 1997-09-30 Eli Lilly And Company Methods of increasing macrophage function
US5389670A (en) * 1993-12-21 1995-02-14 Eli Lilly Company Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
US5593987A (en) * 1993-12-21 1997-01-14 Eli Lilly And Company Methods of inhibiting breast disorders
US5446053A (en) * 1993-12-21 1995-08-29 Eli Lilly And Company Methods of inhibiting dysfunctional uterine bleeding
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
US5478847A (en) * 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
DE4426625A1 (en) * 1994-07-27 1996-03-14 Schering Ag 2-phenylindoles, processes for their preparation, pharmaceutical preparations containing them and their use in the manufacture of medicaments
US5550151A (en) * 1994-08-22 1996-08-27 Eli Lilly Company Methods of reducing scarring in wound healing
US5512296A (en) * 1994-08-22 1996-04-30 Eli Lilly And Company Methods for inhibiting neuronal damage
US5494920A (en) * 1994-08-22 1996-02-27 Eli Lilly And Company Methods of inhibiting viral replication
US5434166A (en) * 1994-08-22 1995-07-18 Eli Lilly And Company Methods of inhibiting demyelinating and desmyelinating diseases
US5496828A (en) * 1994-08-22 1996-03-05 Eli Lilly And Company Methods of inhibiting ulcerative mucositis
US7501441B1 (en) * 1994-09-20 2009-03-10 Eli Lilly And Company Naphthyl compounds, intermediates, processes, compositions, and methods
US6399634B1 (en) 1994-09-20 2002-06-04 Eli Lilly And Company Benzothiophene compounds, compositions, and methods
US5843964A (en) * 1994-09-22 1998-12-01 Eli Lilly And Company Methods of inhibiting endometrial mitoses
US5545641A (en) * 1994-10-20 1996-08-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of bradykinin
US5446071A (en) * 1994-11-18 1995-08-29 Eli Lilly And Company Methods for lowering serum cholesterol
US5637598A (en) 1994-11-18 1997-06-10 Eli Lilly And Company Methods of inhibiting bone loss
US5589482A (en) * 1994-12-14 1996-12-31 Pfizer Inc. Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
US5494929A (en) * 1995-01-12 1996-02-27 Eli Lilly And Company Methods of inhibiting growth hormone effects
US5554600A (en) * 1995-01-20 1996-09-10 Eli Lilly And Company Methods for inhibiting endometriosis
US5521214A (en) * 1995-01-25 1996-05-28 Eli Lilly And Company Methods of inhibiting environmental estrogens
US5512583A (en) * 1995-01-30 1996-04-30 Eli Lilly And Company Methods of decreasing serum calcium levels
US5484808A (en) * 1995-02-09 1996-01-16 Eli Lilly And Company Methods of inhibiting cell-cell adhesion
AU760232B2 (en) * 1995-02-21 2003-05-08 Endorecherche Inc. Benzopyran-containing compounds and method for their use
ZA961564B (en) * 1995-02-28 1997-08-27 Lilly Co Eli Methods of inhibiting ovarian cancer.
US6451817B1 (en) * 1995-03-10 2002-09-17 Eli Lilly And Company Alpha-substituted-1-benzyl-napthyls
US6391892B1 (en) * 1995-03-10 2002-05-21 Eli Lilly And Company Naphthyl pharmaceutical compounds
US6395755B1 (en) * 1995-03-10 2002-05-28 Eli Lilly And Company Benzothiophene pharmaceutical compounds
US6384053B1 (en) 1995-03-10 2002-05-07 Eli Lilly And Company α-substituted-1-benzyl-napthyls
DE19510862A1 (en) * 1995-03-16 1996-09-19 Schering Ag Use of antiestrogens for male fertility control
US6444688B1 (en) * 1995-06-07 2002-09-03 Eli Lilly And Company Compounds and compositions with nitrogen-containing non-basic side chains
CA2220991A1 (en) 1995-06-26 1997-01-16 Eli Lilly And Company Benzothiophene compounds
US5811421A (en) * 1995-07-31 1998-09-22 Eli Lilly And Company Naphthyl and dihydronaphthyl intermediates, compounds, compositions, and methods
US5728724A (en) * 1995-08-17 1998-03-17 Eli Lilly And Company Benzothiophene compounds
DE19604231A1 (en) * 1996-01-29 1997-07-31 Schering Ag Combined pharmaceutical preparation and its use for the treatment of gynecological disorders
US5965551A (en) 1996-02-21 1999-10-12 North Carolina State University Method of treating alopecia
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
US5780497A (en) * 1996-04-19 1998-07-14 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
US5880137A (en) * 1996-04-19 1999-03-09 American Home Products Corporation 2-phenyl-1- 4-(amino-1-yl-alk-1-ynyl)-benzyl!-1H-indol-5-ols as estrogenic agents
SK281737B6 (en) * 1996-04-19 2001-07-10 American Home Products Corporation 2-phenylindol compounds, pharmaceutical composition containing them and their use
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US5985910A (en) * 1996-04-19 1999-11-16 American Home Products Corporation 3- [4- (2- Phenyl-Indole-1-ylmethyl) Phenyl]- Acrylamides as estrogenic agents
CA2206752A1 (en) 1996-07-02 1998-01-02 George Joseph Cullinan Benzothiophene compounds, intermediates, processes, and methods of use
US6713494B1 (en) 1996-08-28 2004-03-30 Eli Lilly And Company Amorphous benzothiophenes, methods of preparation and methods of use
CA2213810C (en) * 1996-08-29 2006-06-06 Lewis Dale Pennington Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods
CA2214070C (en) * 1996-08-29 2006-03-14 Eli Lilly And Company Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
CA2214072C (en) * 1996-08-29 2006-11-14 Eli Lilly And Company Benzo [b] thiophene compounds, intermediates, processes, compositions, and methods
ID19392A (en) * 1996-08-29 1998-07-09 Lilly Co Eli NAFTIL COMPOUNDS AND MIDDLE MATERIALS AND COMPOSITION AND USE METHODS
US6599920B2 (en) 1996-08-29 2003-07-29 Eli Lilly And Company Naphthalene compounds, intermediates, formulations, and methods
CA2214919A1 (en) * 1996-09-24 1998-03-24 Kenneth Lee Hauser Benzothiophene compounds, intermediates, processes, compositions, and methods
MY118009A (en) * 1996-09-25 2004-08-30 Lilly Co Eli Process for the synthesis of benzothiophenes
CA2214931A1 (en) * 1996-09-26 1998-03-26 Henry Uhlman Bryant Tetrahydrobenzo-a-fluorene compounds and method of use
CA2214196A1 (en) * 1996-09-26 1998-03-26 Eli Lilly And Company Benzo[b]indeno[2,1-d]thiophene compounds, intermediates, processes, compositions and methods
CA2214929A1 (en) * 1996-09-26 1998-03-26 Charles Willis Lugar, Iii Naphthofluorene compounds, intermediates, compositions and methods
CA2215856A1 (en) * 1996-09-26 1998-03-26 Eli Lilly And Company Dihydrobenzofluorene compounds, intermediates, compositions, and methods
CA2214935A1 (en) * 1996-09-26 1998-03-26 Henry Uhlman Bryant Benzofluorene compounds, intermediates, compositions, and methods
CA2214922A1 (en) * 1996-09-27 1998-03-27 Eli Lilly And Company Benzothiophene compounds, compositions, and methods
US5948796A (en) * 1996-10-10 1999-09-07 Eli Lilly And Company Benzo B!thiophene compounds, intermediates, formulations, and methods
CA2215647A1 (en) * 1996-10-24 1998-04-24 Eli Lilly And Company Naphthyl compounds, compositions, and methods
CA2216592C (en) * 1996-10-24 2006-07-18 Brian Stephen Muehl Benzothiophene compounds, intermediates, compositions, and methods
CA2214872C (en) * 1996-10-24 2002-01-22 Eli Lilly And Company Benzothiophene compounds, compositions and methods
US6043269A (en) * 1996-10-28 2000-03-28 Novo Nordisk A/S cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
US6153768A (en) * 1996-12-13 2000-11-28 C & C Research Laboratories Benzopyran derivatives
US6117911A (en) * 1997-04-11 2000-09-12 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
JP2002510289A (en) * 1997-04-25 2002-04-02 イーライ・リリー・アンド・カンパニー Indene compound having activity as SERM
CA2236254A1 (en) * 1997-04-30 1998-10-30 David Warren Hoard Process for preparing benzo¬b|thiophenes
HUP0003187A3 (en) * 1997-04-30 2002-04-29 Lilly Co Eli Substituted benzothiophenes and process for preparing them
CA2287918A1 (en) * 1997-04-30 1998-11-05 John Mcneill Mcgill Iii A regioselective alkylation process for preparing substituted benzo¬b|thiophenes
AU7261598A (en) * 1997-04-30 1998-11-24 Eli Lilly And Company Intermediates and a process for preparing benzo{b}thiophenes
CA2231013A1 (en) * 1997-04-30 1998-10-30 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceuticals
JP2001523253A (en) * 1997-04-30 2001-11-20 イーライ・リリー・アンド・カンパニー Intermediates and methods for the preparation of benzo [b] thiophenes
US5760030A (en) * 1997-06-30 1998-06-02 Eli Lilly And Company Benzothiophene compounds and methods of use
WO1999002512A1 (en) * 1997-07-09 1999-01-21 Novo Nordisk A/S Dl-2,3-diaryl-2h-1-benzopyrans
JP2001513501A (en) 1997-08-07 2001-09-04 イーライ・リリー・アンド・カンパニー 1- [4- (Substituted alkoxy) benzyl] naphthalene compounds having estrogen inhibitory activity
US6107346A (en) * 1997-08-11 2000-08-22 Eli Lilly And Company Methods for treating hyperlipidemia
US5908859A (en) * 1997-08-11 1999-06-01 Eli Lilly And Company Benzothiophenes for inhibiting hyperlipidemia
US6090843A (en) * 1997-08-11 2000-07-18 Eli Lilly And Company Benzothiophenes compounds which have useful pharmaceutical activity
US6017914A (en) * 1997-09-03 2000-01-25 Eli Lilly And Company Benzo[b]thiophene compounds, intermediates, formulations, and methods
US5929090A (en) * 1997-09-12 1999-07-27 Eli Lilly And Company 2-aryl-3-aminoaryloxynaphthy1 compounds, intermediates, compositions and methods
US5834488A (en) * 1997-09-19 1998-11-10 Eli Lilly And Company Dihydrobenzo B! indeno 2, 1-D! thiophene compounds, intermediates, processes, compositions and methods
US5990129A (en) * 1997-09-23 1999-11-23 Eli Lilly And Company Methods for regulating trkA expression
ES2217583T3 (en) 1997-10-03 2004-11-01 Eli Lilly And Company BENZOTIOPHENS.
US6005102A (en) * 1997-10-15 1999-12-21 American Home Products Corporation Aryloxy-alkyl-dialkylamines
US6326392B1 (en) 1997-11-06 2001-12-04 American Home Products Corporation Anti-estrogen plus progestin containing oral contraceptives
US6069153A (en) * 1998-05-12 2000-05-30 American Home Products Corporation Indenoindoles and benzocarbazoles as estrogenic agents
US6479535B1 (en) 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
AU4165299A (en) * 1998-06-12 1999-12-30 C & C Research Laboratories Prodrugs of estrogen antagonist
US6353003B1 (en) 1998-06-17 2002-03-05 Eli Lilly And Company Method for reducing levels of homocysteine and C-reactive protein
WO1999066915A2 (en) * 1998-06-23 1999-12-29 Southern Illinois University At Carbondale Therapeutic applications of estrogenic carboxylic acids
CA2340343C (en) * 1998-08-14 2007-04-24 Schering Corporation Enantioselective synthesis
US6262270B1 (en) 1998-08-14 2001-07-17 Schering Corporation Enantioselective synthesis
US6060488A (en) * 1998-09-22 2000-05-09 Eli Lilly And Company Benzothiophenes for treating estrogen deficiency
US6638727B1 (en) * 1999-01-26 2003-10-28 Cytyc Health Corporation Methods for identifying treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
US6380185B1 (en) 1999-03-04 2002-04-30 American Home Products Corporation N-substituted benzoyl indoles as estrogenic agents
US6159959A (en) * 1999-05-06 2000-12-12 American Home Products Corporation Combined estrogen and antiestrogen therapy
HU230543B1 (en) 1999-07-06 2016-11-28 Endorecherche, Inc. Medicament useful for treating and/or suppressing weight gain
EP1219631A4 (en) * 1999-08-23 2003-03-19 Chugai Pharmaceutical Co Ltd Antiandrogen agents
US6380166B1 (en) 1999-09-13 2002-04-30 American Home Products Corporation Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1H-indol-5-ols
US6632557B1 (en) * 1999-10-26 2003-10-14 The Gillette Company Cathodes for metal air electrochemical cells
JP4896335B2 (en) * 2000-03-01 2012-03-14 ナームローゼ・フエンノートチヤツプ・オルガノン Chroman derivatives as estrogen compounds
US6599921B2 (en) 2001-02-22 2003-07-29 Nanodesign, Inc. Non-steroidal estrogen receptor ligands
DE60210283T2 (en) * 2001-05-22 2006-11-09 Eli Lilly And Co., Indianapolis 2-SUBSTITUTED 1,2,3,4-TETRAHYDROCHINOLINES AND DERIVATIVES THEREOF, COMPOSITIONS AND METHODS
WO2002094268A1 (en) * 2001-05-22 2002-11-28 Eli Lilly And Company Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
US7105679B2 (en) 2001-12-19 2006-09-12 Kanojia Ramesh M Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
US7329654B2 (en) 2001-12-19 2008-02-12 Janssen Pharmaceutica N.V. Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
WO2004091488A2 (en) * 2003-04-14 2004-10-28 Merck & Co., Inc. Estrogen receptor modulators
US20060106010A1 (en) * 2003-05-27 2006-05-18 Black Larry J Methods for inhibiting bone loss
US7754709B2 (en) * 2003-06-10 2010-07-13 Solvay Pharmaceuticals Bv Tetracyclic thiophenepyrimidinone compounds as inhibitors of 17β hydroxysteroid dehydrogenase compounds
US7790910B2 (en) 2004-07-27 2010-09-07 Sicor Inc. Process for the preparation of 7α-alkylated 19-norsteroids
CN106038572A (en) 2004-10-20 2016-10-26 恩多研究公司 Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 CGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
US7867538B2 (en) * 2005-12-20 2011-01-11 Archer Daniels Midland Company Processes of improving the quality of oil and products produced therefrom
GB0708376D0 (en) 2007-05-01 2007-06-06 Alligator Bioscience Ab Novel polypeptides and uses thereof
CA2691201A1 (en) * 2007-06-29 2009-01-08 Novogen Research Pty Ltd 2-substituted isoflavonoid compounds, medicaments and uses
US8268806B2 (en) * 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
CA2702710C (en) 2007-10-16 2013-05-07 Repros Therapeutics, Inc. Trans-clomiphene for metabolic syndrome
US8729134B2 (en) 2008-11-14 2014-05-20 Heartlink Limited Aryl di-substituted propenone compounds
CN102459356B (en) * 2009-06-03 2013-06-12 国立大学法人京都大学 Polymerization initiator for living radical polymerization
CN102939287B (en) 2010-06-10 2016-01-27 塞拉根制药公司 Estrogenic agents and uses thereof
WO2011156908A1 (en) 2010-06-16 2011-12-22 Endorecherche, Inc. Methods of treating or preventing estrogen-related diseases
US8853423B2 (en) 2010-06-17 2014-10-07 Seragon Pharmaceuticals, Inc. Indane estrogen receptor modulators and uses thereof
US9193714B2 (en) 2011-12-14 2015-11-24 Seragon Pharmaceuticals, Inc. Fluorinated estrogen receptor modulators and uses thereof
MD20140054A2 (en) 2011-12-16 2014-10-31 Olema Pharmaceuticals, Inc. Novel benzopyran compounds, compositions and uses thereof
ES2681023T3 (en) 2012-02-29 2018-09-11 Repros Therapeutics Inc. Combination therapy to treat androgen deficit
WO2014205138A1 (en) * 2013-06-19 2014-12-24 Seragon Pharmaceuticals, Inc. Estrogen receptor modulator and uses thereof
WO2014203129A1 (en) 2013-06-19 2014-12-24 Olema Pharmaceuticals, Inc. Combinations of benzopyran compounds, compositions and uses thereof
WO2014203132A1 (en) 2013-06-19 2014-12-24 Olema Pharmaceuticals, Inc. Substituted benzopyran compounds, compositions and uses thereof
UA122348C2 (en) * 2015-10-27 2020-10-26 Сан Фарма Адвансед Ресьорч Компані Лімітед Novel heterocyclic antiestrogens
CN108348605B (en) 2015-11-10 2023-06-09 帕拉卡林治疗公司 Treatment of ER-negative breast cancer with PDGF-CC inhibitors and antiestrogens
JP2022541938A (en) * 2019-07-22 2022-09-28 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド selective estrogen receptor degrading agent

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2875199A (en) * 1958-04-22 1959-02-24 Searle & Co Lactones of 17-carboxyalkylated estra-1, 3, 5(10)-triene-3, 17-diols and 3-ethers
US3396169A (en) * 1966-10-26 1968-08-06 Upjohn Co Substituted 2-phenyl-1-(tertiary-aminoalkoxy) phenyl-3, 4-dihydronaphthalenes
DE1518002C3 (en) * 1965-01-02 1975-01-23 Merck Patent Gmbh, 6100 Darmstadt Isoflavans and isoflavens and processes for their production and medicinal products containing them
US3321483A (en) * 1966-06-09 1967-05-23 Bristol Myers Co Substituted 3, 4-dihydro-3-phenyl-4-hydroxy-{[(amino)alkoxy (or alkylthio) phenyl]} thiochroman
US4161540A (en) * 1966-08-22 1979-07-17 Schering Corporation Antiandrogenic agents and methods for the treatment of androgen dependent disease states
US3995060A (en) * 1972-06-20 1976-11-30 Schering Corporation Antiandrogenic agents and method for the treatment of androgen dependent disease states
US3597431A (en) * 1969-07-23 1971-08-03 American Cyanamid Co 1-(4'-substituted-phenyl)-2-(phenyl lower alkyl)-1,2,3,4-tetrahydroisoquinolines
US4139638A (en) * 1976-09-23 1979-02-13 Schering Corporation Methods for the treatment of hirsutism
DE2658307C2 (en) * 1976-12-22 1979-03-15 Klinge Pharma Gmbh & Co, 8000 Muenchen Di-O'-hydroxyphenyD-alkane compounds, process for their preparation and their use as medicaments
FR2465486A1 (en) * 1979-09-21 1981-03-27 Roussel Uclaf NEW APPLICATION USING LH-RH OR AGONISTS
DE2943107C2 (en) * 1979-10-25 1984-07-26 Robert 6600 Saarbrücken Langen Procedure for derusting
US5098903A (en) * 1980-03-07 1992-03-24 Board Of Regents Of The University Of Oklahoma Diphenylcyclopropyl analogs as antiestrogenic and antitumor agents
FR2528434B1 (en) * 1982-06-11 1985-07-19 Roussel Uclaf NOVEL 19-NOR STEROIDS SUBSTITUTED IN 11B AND POSSIBLY IN 2, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS A MEDICAMENT
DE3242894A1 (en) * 1982-11-16 1984-05-17 Schering AG, 1000 Berlin und 4709 Bergkamen 17 alpha -Substituted equilenin derivatives, processes for their preparation and pharmaceuticals containing these
GB8311678D0 (en) * 1983-04-28 1983-06-02 Ici Plc Phenol derivatives
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
GB8410901D0 (en) * 1984-04-27 1984-06-06 Ici Plc Phenol derivatives
GB8410899D0 (en) * 1984-04-27 1984-06-06 Ici Plc Phenol derivatives
IE58417B1 (en) * 1984-04-27 1993-09-22 Ici Plc Chemical derivatives
DE3590389T1 (en) * 1984-08-02 1986-08-28 Schering Corp., Kenilworth, N.J. Pharmaceutical composition for combination therapy of hormone-dependent cancer
US4659695A (en) * 1985-02-08 1987-04-21 Fernand Labrie Method of treatment of prostate cancer
FR2610933B1 (en) * 1987-02-18 1989-06-09 Roussel Uclaf NOVEL 19-NOR STEROIDS SUBSTITUTED IN POSITION 7, THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS, THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2618783B1 (en) * 1987-07-30 1991-02-01 Roussel Uclaf NOVEL 17-ARYL STEROIDS, THEIR PROCESSES AND INTERMEDIATES AS A MEDICAMENT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2630110B1 (en) * 1988-04-13 1990-07-27 Adir NOVEL HETEROAROTINOIDE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US5021432A (en) * 1988-04-26 1991-06-04 Yoshitomi Pharmaceutical Industries, Ltd. Benzopyran compound and its pharmaceutical use
US4950684A (en) * 1988-05-20 1990-08-21 G. D. Searle & Co. 2,2-di-substituted benzopyran leukotriene-D4 antagonists
DE3821148A1 (en) * 1988-06-23 1989-12-28 Erwin Von Dr Angerer AMINO ALKYLINDOLE, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEREOF
US5204337A (en) * 1988-10-31 1993-04-20 Endorecherche Inc. Estrogen nucleus derivatives for use in inhibition of sex steroid activity
HU208150B (en) * 1988-10-31 1993-08-30 Endorecherche Inc Process for producing new estrogen derivatives having steroid hormone inhibitor activity and pharmaceutical compositions comprising such derivatives
IE62715B1 (en) * 1989-03-10 1995-02-22 Endorecherche Inc Combination therapy for treatment of estrogen sensitive diseases
US4963568A (en) * 1989-05-31 1990-10-16 Abbott Laboratories Dopamine agonists
JPH05509078A (en) * 1990-05-17 1993-12-16 ベイラー カレッジ オブ メディシン Growth inhibitory factors and the Act on Measures against Cancer and Cell Proliferative Diseases
DE69023906T2 (en) * 1990-08-09 1996-04-11 Council Scient Ind Res Benzopyrans and process for their preparation.
DE4117512A1 (en) * 1991-05-25 1992-11-26 Schering Ag 2-PHENYLBENZO (B) FURANES AND THIOPHENES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
US5446061A (en) * 1993-11-05 1995-08-29 Eli Lilly And Company Methods for lowering serum cholesterol
US5407947A (en) * 1993-11-05 1995-04-18 Eli Lilly And Company Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans

Similar Documents

Publication Publication Date Title
RU94031127A (en) ACTIVITY INHIBITORS OF GENDER STEROIDS
ES2176190T3 (en) INHIBITORS OF THE ACTIVITY OF SEX STEROIDS.
RU95113862A (en) Pyrrolopyrimidine derivatives, pharmaceutical composition, intermediate compounds
RU2207134C2 (en) Inhibitors of steroid sulfatase
SE7713341L (en) METHOD OF PREPARING BRANCHED AND CYCLOALIFATIC ESTERS FROM THE ANDROSTAN AND OSTRANSERIES
CA2050291A1 (en) Combination therapy for the treatment of estrogen sensitive diseases
KR950031060A (en) Pharmaceutical composition for the treatment of osteoporosis
RU95115547A (en) Steroid compounds, methods of their synthesis and pharmaceutical preparation
DE60027905D1 (en) GLYCOKON JUGATE, GLYCOAMINO ACID, THEIR INTERMEDIATES, AND ITS USE
NO20050216L (en) Steroid conjugates and their preparation and use
KR940021064A (en) How to use pregne derivatives
Flaxman et al. Hormone-independent DNA synthesis by epithelial cells of adult human mammary gland in organ culture
FR2409047A1 (en) ANTIDERMATOMYCOTIC AGENT
ATE40987T1 (en) ACETYLENIC PHENOXYPROPANOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HIGH BLOOD PRESSURE.
NL7800001A (en) METHOD FOR THE PREPARATION OF NEW CHROMOON DERIVATIVES AND THE USE THEREOF AS MEDICINE AGAINST HEART DISEASES
Schuler et al. Immuno-, radio-, and chemotherapeutic studies in head and neck cancer: Highlights of the ASCO Annual Meeting 2017
NL7812403A (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF HUMAN DIARRHEA.
DE60202954D1 (en) TETRAHYDROCHINOLINE DERIVATIVES FOR THE TREATMENT OF DISEASES RELEASED BY HIGH OR LOW OESTROGEN MIRRORS
EA200501568A1 (en) 8β-VINYL 11β- (ω-SUBSTITUTED) ALKILESTRA-1,3,5 (10) -TRIENES
Koechel et al. Synthesis and pharmacology of an epoxide derivative of ethacrynic acid
BROWN The effect of 17 alpha-ethynylestradiol on the radiation sensitivity of mice[Ph. D. Thesis]
KR930012025A (en) Herbal hepatitis B treatment
ES8506710A1 (en) Ambroxol theophylline-7-acetate
Aakvaag et al. Progesterone and androgens in cyst fluid and vein blood in the human ovary
RU98112707A (en) DRUG FOR TREATMENT OF SKIN CANCER AND PRE-CANCER SKIN DISEASES